The9 Ltd ADR NCTY
News
The9 Reports US$32 Million Net Income for Second Quarter of 2026, Up Over 39% Sequentially
The9's Investee Nanyang Biologics (NYB) Advancing toward Nasdaq Listing after RFAI Cleared Vote at Shareholders Extraordinary General Meeting
The9 Limited to Report Second Quarter 2026 Results on August 24, 2026
The9 Investee Nanyang Biologics (NYB) Advancing Planned Nasdaq Listing for the US$1.5 Billion Business Combination
The9 Expands Brand Partnership Network Across Southeast Asia
